11/92 (12.0%, 95% CI 6.1–20.4%), odds ratio (OR) 0.35, 95% CI 0.09–1.29, p = 0.10); however, the association did not reach statistical significance.
← all excerpts
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.
2
—
—
The sentences
COVID-19 patients with vaccination showed a trend of lower incidence of severe COVID-19 when compared to unvaccinated groups (3/67 (4.5%, 95% CI 0.9–12.5%) vs. 11/92 (12.0%, 95% CI 6.1–20.4%), odds ratio (OR) 0.35, 95% CI 0.09–1.29, p = 0.10); however, the association did not reach statistical significance.